NEUROFIBROMATOSIS 1 (NF1)
Clinical trials for NEUROFIBROMATOSIS 1 (NF1) explained in plain language.
Never miss a new study
Get alerted when new NEUROFIBROMATOSIS 1 (NF1) trials appear
Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1 (NF1), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets shrinking untreatable nerve tumors
Disease control OngoingThis study is testing whether the drug selumetinib can shrink or slow the growth of large, inoperable nerve tumors (plexiform neurofibromas) in adults with Neurofibromatosis Type 1 (NF1). Participants take capsules twice daily for as long as they tolerate the drug and their disea…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Laser zaps tumors in genetic skin condition
Symptom relief TerminatedThis study is testing whether monthly treatments with a specific type of laser can safely reduce the size and improve the appearance of skin tumors in adults with Neurofibromatosis Type 1 (NF1). Researchers will give up to six laser treatments and measure changes in the tumors, p…
Matched conditions: NEUROFIBROMATOSIS 1 (NF1)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Apr 01, 2026 14:42 UTC